Does REVLIMID Cause Mantle cell lymphoma? 17 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 17 reports of Mantle cell lymphoma have been filed in association with REVLIMID. This represents 0.2% of all adverse event reports for REVLIMID.
17
Reports of Mantle cell lymphoma with REVLIMID
0.2%
of all REVLIMID reports
12
Deaths
5
Hospitalizations
How Dangerous Is Mantle cell lymphoma From REVLIMID?
Of the 17 reports, 12 (70.6%) resulted in death, 5 (29.4%) required hospitalization.
Is Mantle cell lymphoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for REVLIMID. However, 17 reports have been filed with the FAERS database.
What Other Side Effects Does REVLIMID Cause?
Pneumonia (652)
Plasma cell myeloma (632)
Death (565)
Diarrhoea (508)
Thrombosis (484)
Fatigue (448)
Platelet count decreased (362)
Full blood count decreased (352)
Deep vein thrombosis (332)
Pancytopenia (319)
What Other Drugs Cause Mantle cell lymphoma?
RITUXIMAB (352)
IBRUTINIB (321)
BORTEZOMIB (184)
LENALIDOMIDE (179)
VENETOCLAX (174)
CYCLOPHOSPHAMIDE (120)
CYTARABINE (114)
VINCRISTINE (112)
BENDAMUSTINE (109)
DOXORUBICIN (108)
Which REVLIMID Alternatives Have Lower Mantle cell lymphoma Risk?
REVLIMID vs REVOLADE
REVLIMID vs REVUMENIB
REVLIMID vs REYATAZ
REVLIMID vs REZAFUNGIN
REVLIMID vs RIBASPHERE